| 000 | 01866 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517162010.0 | ||
| 264 | 0 | _c20180618 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1557-3125 | ||
| 024 | 7 |
_a10.1158/1541-7786.MCR-17-0211 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEmery, Caroline M | |
| 245 | 0 | 0 |
_aBRAF-inhibitor Associated MEK Mutations Increase RAF-Dependent and -Independent Enzymatic Activity. _h[electronic resource] |
| 260 |
_bMolecular cancer research : MCR _c10 2017 |
||
| 300 |
_a1431-1444 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAllosteric Site |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMAP Kinase Kinase 1 _xchemistry |
| 650 | 0 | 4 |
_aMAP Kinase Kinase 2 _xchemistry |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aProtein Structure, Secondary |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xchemistry |
| 650 | 0 | 4 |
_araf Kinases _xmetabolism |
| 700 | 1 | _aMonaco, Kelli-Ann | |
| 700 | 1 | _aWang, Ping | |
| 700 | 1 | _aBalak, Marissa | |
| 700 | 1 | _aFreeman, Alyson | |
| 700 | 1 | _aMeltzer, Jodi | |
| 700 | 1 | _aDelach, Scott M | |
| 700 | 1 | _aRakiec, Daniel | |
| 700 | 1 | _aRuddy, David A | |
| 700 | 1 | _aKorn, Joshua M | |
| 700 | 1 | _aHaling, Jacob | |
| 700 | 1 | _aAcker, Michael G | |
| 700 | 1 | _aCaponigro, Giordano | |
| 773 | 0 |
_tMolecular cancer research : MCR _gvol. 15 _gno. 10 _gp. 1431-1444 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1541-7786.MCR-17-0211 _zAvailable from publisher's website |
| 999 |
_c27317407 _d27317407 |
||